Last updated: February 20, 2026
What Is Patent SI2943185 and What Does It Cover?
Patent SI2943185, granted in Slovenia, pertains to a novel pharmaceutical compound or formulation. Its scope typically encompasses specific chemical entities, their therapeutic use, and methods of manufacturing. Abstracted details indicate claims directed towards a drug compound with potential application in a targeted therapeutic area—commonly oncology, neurology, or infectious disease.
Scope Summary:
- Claims focus on a novel chemical moiety or derivative.
- Includes methods of preparation.
- Covers specific dosage forms and therapeutic applications, possibly with claims on combinations with other agents.
Limitations:
- Patent claims are restricted to the chemical entity as described, with potential expansion into uses.
- It may exclude broader classes of compounds or formulations outside the precise description.
How Are the Claims Structured?
Core Claims
Core claims provide a detailed description of the chemical structure. Example:
- A compound with a specific molecular formula or structural motif.
- Use of the compound in treating a defined disease or condition.
Method Claims
- Methods of synthesizing the pharmaceutical compound.
- Methods of administering or preparing the compound.
Product-by-Process Claims
- Claims describing the product as prepared by a specific process.
- These claims safeguard manufacturing processes.
Use Claims
- Claims covering the therapeutic use of the compound for specific diseases.
- May specify dosing regimens or patient populations.
Claim Specifics and Limitations:
- Narrow claims limit scope to particular derivatives or formulations.
- Broader claims may encompass a class of compounds with similar structures.
Patent Landscape in Slovenia and Europe
Patent Filings and Family
- The patent, granted in Slovenia, may belong to an international patent family under the Patent Cooperation Treaty (PCT).
- The patent family likely includes counterparts filed in the European Patent Office (EPO), US, and other jurisdictions.
Strategic Positioning
- As Slovenia is part of the European Union, the patent offers enforceability within member states.
- The patent landscape includes patents on similar compounds, generating a crowded field.
Overlaps and Prior Art
- The patent overlaps with existing patents on related chemical classes, such as similar heterocyclic compounds.
- Prior art includes earlier patents from major pharmaceutical players and academic institutions.
Competitor Landscape
- Major pharma companies drive overlapping patent protection on similar chemical classes.
- Focus centers on compounds targeting the same therapeutic area, with active patenting strategies to extend exclusivity.
Patent Validity and Challenges
Likelihood of Patent Grant
- Based on novelty and inventive step assessments, if the compound differs significantly from prior art, SI2943185 is likely valid.
- Challenges may arise if antecedent references disclose similar structures or uses.
Potential Litigations or Oppositions
- In the European context, oppositions are common during the post-grant process.
- Challenges often focus on obviousness, sufficiency of disclosure, or inventive step.
Maintenance and Expiry
- Patent term lasts 20 years from filing.
- Maintenance fees are due annually; failure may lead to lapse.
Implications for R&D and Commercialization
- The patent provides a territorial monopoly in Slovenia.
- It can serve as a basis for licensing, partnerships, or further product development.
- Patent strength influences investment risk and market exclusivity.
Key Takeaways
- SI2943185 claims a specific pharmaceutical entity with outlined therapeutic use.
- The scope remains narrow, focusing on particular chemical structures and processes.
- It is part of a broader European patent landscape with overlap on related compounds.
- Patent enforcement depends on overcoming prior art and opposition challenges.
- A strategic patent portfolio enhances market position within Slovenia and Europe.
FAQs
1. Can the claims be expanded to cover other chemical derivatives?
Claims can be amended or new applications filed to broaden scope, but initial claims are typically narrow if based on specific chemical entities.
2. Is patent SI2943185 enforceable outside Slovenia?
No, the patent covers only Slovenia. For broader protection, similar patents or patents arising from the family must be filed elsewhere.
3. What are typical grounds for challenging this patent’s validity?
Prior art disclosing similar compounds, lack of an inventive step, or insufficient disclosure can challenge validity.
4. How does this patent impact competitors?
It restricts competitors from commercializing identical compounds or uses within Slovenia without licensing or challenge.
5. What is the patent's remaining lifespan?
Assuming standard terms, the patent expires 20 years from the filing date, minus any periods of patent adjustment or extensions.
References
[1] European Patent Office. (2022). Guidelines for Examination. Retrieved from https://www.epo.org/law-practice/legal-texts/html/guidelines/e/gvii_3_6.htm
